We use cookies for a better user experience. Read our Privacy Policy
I Agree
Microarray Scanners Market
SARS-CoV-2 is a betacoronavirus, which has led to the worldwide spread of the novel infection. Such trends have accelerated research and development (R&D) in the healthcare sector, including the microarray scanners market. GeneCopoeia - the largest provider of expression-ready clones is publicizing its OmicsArray™ SARS-CoV-2 coronavirus Antigen Microarray, owing to its capability of multiplexing, high throughput, and high sensitivity.
Companies in the microarray scanners market are increasing their focus in gene expression and drug discovery to address the novel coronavirus infection. They are increasing the availability of antigen microarrays that help detect antibodies against SARS-CoV-2 and other pathogens. Protein microarrays are also being preferred for powerful detection of antibodies associated with virus infections, including SARS-CoV-2, SARS-CoV-1, and influenza, among others. Viral proteins are chosen based on a thorough review of peer-reviewed publications.
Request a sample to get extensive insights into the Microarray Scanners Market
Emerging infectious diseases with little known mechanisms of infection and pathogenicity represent a big challenge for stakeholders in the life sciences industry, research, and clinics. In order to overcome this challenge, companies in the microarray scanners market are providing dedicated glycan arrays to enhance research activities and define precise mechanisms of virus and bacterial infection. Innopsys - a provider of cutting-edge instruments and software for research & diagnostics is gaining recognition for its glycan arrays and high density peptide arrays that are precious tools for understanding immune response, validating vaccines, and defining immunogenic epitomes.
The high-density peptide arrays hold promising potential in the discovery of host-pathogen interactions, pathogen epitopes, and patient immune responses that are essential for the development of new and preventive therapeutic approaches such as for drugs and vaccines.
To understand how our report can bring difference to your business strategy, Ask for a brochure
The microarray scanners market is predicted to surpass ~27,000 units by the end of 2030. Companies in the microarray scanners market are entering into strategic partnerships to increase the availability of high technology solutions pertaining to innovative microarray platforms for viral infections screening and protein biomarkers analysis. This is being achieved with the help of near-infrared fluorescence, which explains why fluorescence microarray scanners are estimated to dominate the highest revenue among all product types in the market and during the assessment period.
The R&D innovations in fluorescence microarray scanners holds promising potential in the protein biomarkers analysis with respect to Zika, Dengue, and SARS-CoV-2, among others. Proprietary gold-coated slides based on nanotechnology are being used in scanners. This technology deploys superior sensitivity and precision for the detection of sera antibodies developed by infected patients.
The microarray scanners market is expected to reach 1.5 Bn by 2030. However, CMOS (Complementary Metal-Oxide Semiconductor) imaging sensors are emerging as an alternative to CCD (Charge Coupled Device) image sensors, as CCD sensors consume increased power as compared to CMOS sensors. As such, CCD sensors help create high quality and low noise images, whereas CMOS sensors are usually more susceptible to noise.
On the other hand, CMOS sensors are much less expensive to manufacture than CCD sensors and are rapidly improving performance. Such trends are likely to affect revenue generation in the microarray scanners market. Hence, companies in the market should fuel their manufacturing by increasing R&D in CMOS imaging sensors. As such, it has been found that CCD sensors are still required for certain demanding applications. Thus, device manufacturers should weigh the pros and cons of CCD image sensors to stay relevant to ongoing trends in the market.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Microarray Scanners Market
Analysts’ Viewpoint
In the light of the ongoing COVID-19 outbreak, companies are increasing the availability of glycan arrays and high-density peptide arrays that play a crucial role in understanding immune response, validating vaccines, and defining immunogenic epitomes. However, CMOS imaging sensors are emerging as an alternative to CCD imaging sensors, owing to their cost efficient and low power consumption advantages. Hence, stakeholders in the microarray scanners market should consider weighing the pros and cons of CCD & CMOS, whilst identifying how CCD is being used in demanding applications with the help of microarray scanners. Companies in the microarray scanners market should enter into strategic partnerships to advance in near-infrared fluorescence, which helps in detection of sera antibodies developed by infected patients.
Microarray Scanners Market – Segmentation
| Product Type |
|
| Application |
|
| End User |
|
| Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
The global microarray scanners market was worth US$ 700 Mn and is projected to reach a value of US$ 1.5 Bn by the end of 2030
Microarray scanners market is anticipated to grow at a CAGR of 7% during the forecast period
North America accounted for a major share of the global microarray scanners market
Microarray scanners market is driven by rise in demand for preventive healthcare, well-established healthcare facilities, rapidly increasing geriatric population, and high per capita healthcare expenditure are anticipated to drive the global market from 2020 to 2030
Key players in the global microarray scanners market include Thermo Fisher Scientific, Agilent Technologies, Illumina, Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., GE Healthcare (General Electric Company), Molecular Devices, LLC (Danaher Corporation), Innopsys Inc., and Berthold Technologies GmbH & Co. KG
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Microarray Scanners Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Microarray Scanners Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. User Base for OncoScanand CytoSNPin EU5 Countries
5.4. Number of labs with the instruments such as iScan, NextSeq550, GeneChip Scanner 3000 7G, GeneChip Scanner 3000 Dx2 that can run CytoSNP& OncoScan
5.5. Bioinformatics platforms that are being used with these instruments
5.6. % of these instruments are used for clinical decision making
5.7. Effort (time/cost) required to operationalize / validate these instruments
5.8. Workflow details – batch size, TAT, cost/test
5.9. Covid-19 Impact Analysis
6. Global Microarray Scanners Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type , 2018–2030
6.3.1. Fluorescence Microarray Scanners
6.3.2. Charge-coupled Devices Microarray Scanners
6.3.3. Colorimetric Microarray Scanners
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Microarray Scanners Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2018–2030
7.3.1. Gene Expression
7.3.2. Drug Discovery
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Microarray Scanners Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2018–2030
8.3.1. Hospitals
8.3.2. Diagnostic Laboratories
8.3.3. Pharmaceutical & Biotechnology Companies
8.3.4. Academic & Research Institutes
8.4. Market Attractiveness Analysis, by End-user
9. Global Microarray Scanners Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Microarray Scanners Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2018–2030
10.2.1. Fluorescence Microarray Scanners
10.2.2. Charge-coupled Devices Microarray Scanners
10.2.3. Colorimetric Microarray Scanners
10.2.4. Others
10.3. Market Value Forecast, by Application, 2018–2030
10.3.1. Gene Expression
10.3.2. Drug Discovery
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2018–2030
10.4.1. Hospitals
10.4.2. Diagnostic Laboratories
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Academic & Research Institutes
10.5. Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Microarray Scanners Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2018–2030
11.2.1. Fluorescence Microarray Scanners
11.2.2. Charge-coupled Devices Microarray Scanners
11.2.3. Colorimetric Microarray Scanners
11.2.4. Others
11.3. Market Value Forecast, by Application, 2018–2030
11.3.1. Gene Expression
11.3.2. Drug Discovery
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2018–2030
11.4.1. Hospitals
11.4.2. Diagnostic Laboratories
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Academic & Research Institutes
11.5. Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Microarray Scanners Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2018–2030
12.2.1. Fluorescence Microarray Scanners
12.2.2. Charge-coupled Devices Microarray Scanners
12.2.3. Colorimetric Microarray Scanners
12.2.4. Others
12.3. Market Value Forecast, by Application, 2018–2030
12.3.1. Gene Expression
12.3.2. Drug Discovery
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2018–2030
12.4.1. Hospitals
12.4.2. Diagnostic Laboratories
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Academic & Research Institutes
12.5. Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Microarray Scanners Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2018–2030
13.2.1. Fluorescence Microarray Scanners
13.2.2. Charge-coupled Devices Microarray Scanners
13.2.3. Colorimetric Microarray Scanners
13.2.4. Others
13.3. Market Value Forecast, by Application, 2018–2030
13.3.1. Gene Expression
13.3.2. Drug Discovery
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2018–2030
13.4.1. Hospitals
13.4.2. Diagnostic Laboratories
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Academic & Research Institutes
13.5. Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Microarray Scanners Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2018–2030
14.2.1. Fluorescence Microarray Scanners
14.2.2. Charge-coupled Devices Microarray Scanners
14.2.3. Colorimetric Microarray Scanners
14.2.4. Others
14.3. Market Value Forecast, by Application, 2018–2030
14.3.1. Gene Expression
14.3.2. Drug Discovery
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2018–2030
14.4.1. Hospitals
14.4.2. Diagnostic Laboratories
14.4.3. Pharmaceutical & Biotechnology Companies
14.4.4. Academic & Research Institutes
14.5. Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis by Company (2020)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Growth Strategies
15.3.1.3. SWOT Analysis
15.3.2. Agilent Technologies
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Growth Strategies
15.3.2.3. SWOT Analysis
15.3.3. Illumina, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. PerkinElmer, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. F. Hoffmann-La Roche Ltd.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. GE Healthcare (General Electric Company)
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. Molecular Devices, LLC (Danaher Corporation)
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Innopsys, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9. Berthold Technologies GmbH & Co. KG
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Growth Strategies
15.3.9.3. SWOT Analysis
List of Tables
Table 1.1: List of Labs Using Microarray Instruments, by Country
Table 1.2: List of Labs Using Microarray Instruments, by Country
Table 02: User Base for OncoScan and CytoSNP in EU5 Countries
Table 03: Number of labs with the Microarray instruments in EU5 Countries
Table 04: Effort (time/cost) required to operationalize/validate Microarray instruments (Germany)
Table 05: Effort (time/cost) required to operationalize/validate Microarray instruments (U.K.)
Table 06: Effort (time/cost) required to operationalize/validate Microarray instruments (France)
Table 07: Effort (time/cost) required to operationalize/validate Microarray instruments (Italy)
Table 08: Effort (time/cost) required to operationalize/validate Microarray instruments (Spain)
Table 09: Effort (time/cost) required to operationalize/validate Microarray instruments
Table 10: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 11: Global Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 12: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 13: Global Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 14: Global Microarray Scanners Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 15: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 16: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 17: North America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 18: North America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 19: North America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 20: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 21: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 22: Europe Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 23: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24: Europe Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 27: Asia Pacific Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 28: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 29: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 30: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 31: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 32: Latin America Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 33: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 34: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 35: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 36: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 37: Middle East & Africa Microarray Scanners Market Volume (Units) Forecast, by Product Type, 2018–2030
Table 38: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 39: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Microarray Scanners Market Value Share, by Product Type, 2019
Figure 03: Global Microarray Scanners Market Value Share, by End-user, 2019
Figure 04: Global Microarray Scanners Market Value Share, by Application, 2019
Figure 05: Global Microarray Scanners Market Value Share, by Region, 2019
Figure 06: Global Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 07: Global Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 08: Global Microarray Scanners Market Revenue (US$ Mn), by Fluorescence Microarray Scanners, 2018–2030
Figure 09: Global Microarray Scanners Market Revenue (US$ Mn), by Charge-coupled Devices Microarray Scanners, 2018–2030
Figure 10: Global Microarray Scanners Market Revenue (US$ Mn), by Colorimetric Microarray Scanners, 2018–2030
Figure 11: Global Microarray Scanners Market Revenue (US$ Mn), by Others, 2018–2030
Figure 12: Global Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 13: Global Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 14: Global Microarray Scanners Market Revenue (US$ Mn), by Gene Expression, 2018–2030
Figure 15: Global Microarray Scanners Market Revenue (US$ Mn), by Drug Discovery, 2018–2030
Figure 16: Global Microarray Scanners Market Revenue (US$ Mn), by Others, 2018–2030
Figure 17: Global Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 18: Global Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Figure 19: Global Microarray Scanners Market Revenue (US$ Mn), by Hospitals, 2018–2030
Figure 20: Global Microarray Scanners Market Revenue (US$ Mn), by Diagnostic Laboratories, 2018–2030
Figure 21: Global Microarray Scanners Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2018–2030
Figure 22: Global Microarray Scanners Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030
Figure 23: Global Microarray Scanners Market Value Share Analysis, by Region, 2019 and 2030
Figure 24: Global Microarray Scanners Market Attractiveness Analysis, by Region, 2020–2030
Figure 25: North America Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 26: North America Microarray Scanners Market Value Share Analysis, by Country, 2019 and 2030
Figure 27: North America Microarray Scanners Market Attractiveness Analysis, by Country, 2020–2030
Figure 28: North America Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 29: North America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 30: North America Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 31: North America Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 32: North America Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 33: North America Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Figure 34: Europe Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 35: Europe Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 36: Europe Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 37: Europe Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 38: Europe Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 39: Europe Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 40: Europe Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 41: Europe Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 42: Europe Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Figure 43: Asia Pacific Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 44: Asia Pacific Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 45: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 46: Asia Pacific Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 47: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 48: Asia Pacific Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 49: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 50: Asia Pacific Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 51: Asia Pacific Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Figure 52: Latin America Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 53: Latin America Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 54: Latin America Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 55: Latin America Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 56: Latin America Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 57: Latin America Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 58: Latin America Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 59: Latin America Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 60: Latin America Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Figure 61: Middle East & Africa Microarray Scanners Market Value (US$ Mn) Forecast, 2018–2030
Figure 62: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 63: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 64: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 65: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 66: Middle East & Africa Microarray Scanners Market Value Share Analysis, by Application, 2019 and 2030
Figure 67: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by Application, 2020–2030
Figure 68: Middle East & Africa Microarray Scanners Market Value Share Analysis, by End-user, 2019 and 2030
Figure 69: Middle East & Africa Microarray Scanners Market Attractiveness Analysis, by End-user, 2020–2030
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
